Study Reports Clause Samples

Study Reports. Licensor shall provide Company with (i) a quarterly progress study report within thirty (30) days after the end of each calendar quarter with respect to the performance of the Research Program, (ii) a comprehensive final study report for each study within [*] days after completion of such study, including the full data set and results of the applicable study, and (iii) a comprehensive final report for the Research Program within [*] days after the expiration or earlier termination of the Research Program.

Study Reports. The Lead Study Party (as the sponsor) for a given Clinical Trial for the Licensed Product pursuant to a Development Plan shall provide the other Party with an electronic draft of the final study report for such Clinical Trial as soon as reasonably practicable after completion of the Clinical Trial, for such other Party to provide comments to the Lead Study Party, which comments shall be provided within [ * ] days of receipt of the draft of such final study report. The Lead Study Party shall consider in good faith such comments and, at either Party’s reasonable request, the Parties shall meet in person or via teleconference within ten (10) Business Days after the Lead Study Party’s receipt of such comments to discuss such comments in good faith. The Lead Study Party shall provide the other Party with a copy of the final study report for a given study promptly after such final study report is available. In the event that a given Clinical Trial under the Development Plan is for a Proprietary Combination, the Lead Study Party shall not include any statements in the study report relating to the applicable Proprietary Product which have not been approved by the applicable Proprietary Product Party, unless otherwise required by Applicable Law.

Study Reports. Upon the reasonable request of SPONSOR, INSTITUTION and PRINCIPAL INVESTIGATOR shall submit reports (whether orally or in writing which will be stipulated by SPONSOR at the time of the request) on the progress of the Studies; written reports, including but not limited to, status of the budget, and Studies subject recruitment, which will be provided within thirty (30) days of a request from SPONSOR.

Study Reports. A. Provide final statistical report R E B. Prepare primary publication R E C. Prepare subsequent publications / abstracts R E APPENDIX C is set out on the following pages. STATEMENT OF POLICY REGARDING OWNERSHIP OF DATA/MATERIALS This Statement sets forth the policy of the NSABP Foundation, Inc. (“Foundation” or “NSABP”) with respect to ownership of certain data, physical specimens and intellectual property resulting from the conduct of NSABP sponsored clinical research. 1. It is the policy of the Foundation that the aggregate data, serum, tissues and other materials resulting from the conduct of NSABP clinical research and provided by a participating facility to the Foundation or to a participating research site or designated contracted entity at the direction of the Foundation (“Data/Materials”) constitute property entrusted to the care and management of the Foundation to be used for the benefit of the public, and that the Foundation is the owner of such Data/Materials. All worldwide right, title and interest in the intellectual property rights with respect to such Data/Materials shall be owned by NSABP, including the right of first publication as provided in the NSABP Publication Policy, all patent rights and all rights of copyright. 2. All Research Collaborators of the NSABP and all contracted entities of the NSABP participating in its clinical research shall be responsible for protecting and preserving the integrity of the Data/Materials in their possession and shall deliver the same to the Foundation or its designee as required by the contractual agreement and protocol. 3. The foregoing notwithstanding, nothing in this statement shall be construed as granting NSABP ownership of any intellectual property, including original works of authorship, inventions, discoveries or any patents or copyrights issued thereon, made by participants or their personnel independently of information, drugs or instructional materials provided by NSABP or the study sponsors. Research Collaborators and other contracted entities shall not, however, obtain intellectual property rights to any of the data, information, protocols or drugs provided by NSABP or study sponsors, nor shall Research Collaborators and other contracted entities have any interest in intellectual property rights resulting merely from their routine activities in carrying out the study protocols or other activities in accordance with instructions from NSABP or the study sponsors. Any invention or discovery ...

Study Reports.  A Study Report shell should be created for presenting key data from the Study Dashboard which will be reviewed regularly at study meeting. Links to guidance documents and example templates for Study Reports are provided in the Appendix.

Study Reports. HDR will obtain reports and plans from relevant and recent studies conducted by the AAMPO and other relevant agencies. The 2023 Iowa Strategic Highway Safety Plan, 2023 VRU Safety Assessment and Iowa DOT Systemic Bicycle and Pedestrian Safety Analysis, and any past county / local road safety plans organized by the Iowa DOT that overlap the AAMPO boundary will be collected for use in the CSAP. • Input to the MTP Data Collection Technical Memorandum – which will be a brief summary of the data collected and a list of sources. • One round of review (electronic) by the AAMPO for up to one week on the data collection memorandum.

Study Reports. In addition to any reports required in the sections on Safety, the Sponsor and Principal Investigator shall provide Company with an interim investigator report every six (6) months, including a summary of Subject accrual to date of reporting. A final draft of the manuscript resulting from the Study will serve as a final report; however, in the event a manuscript is not forthcoming, a final study report will be submitted, including a summary of Subject accrual, results of all data analyses, and final conclusions. All reports shall be provided in English language.

Study Reports. Studies Continued from Year 1 New Studies Initiated in Year 2